World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 35

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7025)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

401

WORD

HTML

3815

Tables (1-3)

524

Sum=4801

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

248

Download

676

Sum=924

Publishing Process of This Article

Item

Count

Browse

335

Download

672

Sum=1007

Sep 21, 2023 (publication date) through Nov 2, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Zhou B, Zhang SR, Chen G, Chen P. Developments and challenges in neoadjuvant therapy for locally advanced pancreatic cancer. World J Gastroenterol 2023; 29(35): 5094-5103 [PMID: 37744290 DOI: 10.3748/wjg.v29.i35.5094]
URL:	https://www.wjgnet.com/1007-9327/full/v29/i35/5094.htm

Number	Citing Articles
1	Deirdre J Cohen, Judith D Goldberg, Lawrence Leichman, Tsivia Hochman, Elliot Newman, Kevin Du, Alec Megibow, Paul Oberstein, Raed Al-Rajabi, Aaron J Scott, Tanios Bekaii-Saab, Wells A Messersmith, Colin Weekes. Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study. The Oncologist 2025; 30(10) doi: 10.1093/oncolo/oyaf271
2	Yi Chen, Liu-Yan Li, Jian-Di Li, Rong-Quan He, Zhi-Guang Huang, Wan-Ying Huang, Jia-Yuan Luo, Yi-Wu Dang, Gang Chen, Dan-Ming Wei. Expression, potential biological behaviour and clinical significance of MCM3 in pancreatic adenocarcinoma: a comprehensive study integrating high throughput sequencing, CRISPR screening and in-house immunohistochemistry. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2405879
3	Shi-Qiong Zhou, Peng Wan, Sen Zhang, Yuan Ren, Hong-Tao Li, Qing-Hua Ke. Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma. World Journal of Clinical Oncology 2024; 15(7): 859-866 doi: 10.5306/wjco.v15.i7.859 Abstract(460) \| Core Tip(559) \| Full Article(HTML)(1350) \| Full Article with Cover (PDF)-657K(126) \| Audio-327K(14) \| Peer-Review Report-198K(89) \| Answering Reviewers-142K(73) \| Full Article (PDF)-420K(133) \| Full Article (XML)-117K(119) \| Times Cited (5) \| Total Visits (5643) \| Open
4	Dongdong Wu, Ning Liu, Hao Dong, Kan Zhou, Lei Du, Ying Li, Yanjun Chao, Fuping Ma. Efficacy and safety of neoadjuvant systemic therapy in resectable hepatocellular carcinoma: a Systematic Review and meta-analysis. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1504917
5	Robert Michael O’Connell, Emir Hoti. Neoadjuvant Stereotactic Ablative Radiotherapy in Pancreatic Ductal Adenocarcinoma: A Review of Perioperative and Long-Term Outcomes. Diseases 2025; 13(7): 214 doi: 10.3390/diseases13070214